comparemela.com

Latest Breaking News On - Volition veterinary diagnostics development - Page 1 : comparemela.com

VolitionRx Limited Announces Third Quarter 2023 Financial Results and Business Update

Conference call to discuss financial and operational results scheduled for Wednesday, November 15, at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev., Nov. 14, 2023 /PRNewswire/ — VolitionRx Limited (NYSE American: VNRX) (“Volition”) today announced financial results and a business update for the third quarter ended September 30, 2023. Volition management will host a conference call tomorrow, […]

Volition and VPG Launch Nu Q® Vet Cancer Test in UK & Ireland

Volition and VPG Launch Nu Q® Vet Cancer Test in UK & Ireland
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

VolitionRx joins up with VPG to launch Nu Q Vet Cancer Test in UK and Ireland

VolitionRx (NYSE-A:VNRX) told investors it has joined forces with Veterinary Pathology Group (VPG) to launch the Nu.Q Vet Cancer Test to veterinary.

US Ambassador Adler visits Belgian Volition

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, welcomed Ambassador Michael M. Adler, U.S. Ambassador to the Kingdom of Belgium for a tour of its purpose-built research, development and manufacturing facilities situated in Isnes, Belgium.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.